FNArena’s Monitor keeps track of corporate earnings result releases, including broker views, ratings and target price changes and beat/miss assessments
Analysts suggest GQG Partners’ strong investment performance should lead to ongoing positive net flows, but when is that operational leverage ready to kick in?
FNArena’s Monitor keeps track of corporate earnings result releases, including broker views, ratings and target price changes and beat/miss assessments
The New Criterion’s Tim Boreham highlights Arovella Therapeutics in a struggling cell therapies sector worldwide
Australian’s once cozy duopoly for poultry products is breaking down, adding one extra challenge for market leader Inghams Group
FNArena’s Monitor keeps track of corporate earnings result releases, including broker views, ratings and target price changes and beat/miss assessments
Endeavour Group posted a resilient FY24 result, but faces ongoing challenges in FY25
Tony Sycamore, Market Analyst, IG shares his technical analysis views on the Nasdaq100, the ASX200 and crude oil
The second half of 2024 is poised to have a pivotal impact on Australia for the rest of the decade, argues Scott Solomon, Co-Portfolio Manager of the T. Rowe Price Dynamic Global Bond Strategy
FNArena’s Monitor keeps track of corporate earnings result releases, including broker views, ratings and target price changes and beat/miss assessments
